Douglas D. Richman

77.5k total citations · 27 hit papers
509 papers, 55.6k citations indexed

About

Douglas D. Richman is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Douglas D. Richman has authored 509 papers receiving a total of 55.6k indexed citations (citations by other indexed papers that have themselves been cited), including 390 papers in Virology, 347 papers in Infectious Diseases and 140 papers in Epidemiology. Recurrent topics in Douglas D. Richman's work include HIV Research and Treatment (389 papers), HIV/AIDS drug development and treatment (282 papers) and HIV/AIDS Research and Interventions (239 papers). Douglas D. Richman is often cited by papers focused on HIV Research and Treatment (389 papers), HIV/AIDS drug development and treatment (282 papers) and HIV/AIDS Research and Interventions (239 papers). Douglas D. Richman collaborates with scholars based in United States, United Kingdom and France. Douglas D. Richman's co-authors include Diane V. Havlir, Celsa A. Spina, Susan J. Little, Margaret A. Fischl, Paul A. Volberding, Huldrych F. Günthard, Joseph K. Wong, Donna M. Jacobsen, Martin Hirsch and Scott M. Hammer and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Douglas D. Richman

504 papers receiving 53.7k citations

Hit Papers

Identification of a Reser... 1987 2026 2000 2013 1997 1987 1997 1997 2012 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
    1997 2.4k citations Douglas D. Richman, Robert F. Siliciano et al. profile →
  2. The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
    1987 2.3k citations Douglas D. Richman et al. profile →
  3. Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
    1997 1.7k citations Joseph K. Wong, Huldrych F. Günthard et al. profile →
  4. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
    1997 1.5k citations John W. Mellors, Douglas D. Richman et al. profile →
  5. Antiretroviral Treatment of Adult HIV Infection
    2012 1.4k citations Douglas D. Richman, Donna M. Jacobsen et al. profile →
  6. HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
    1989 1.3k citations Douglas D. Richman et al. profile →
  7. The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
    1987 975 citations Douglas D. Richman et al. profile →
  8. Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
    1990 951 citations Richard C. Reichman, William D. Hardy et al. profile →
  9. Rapid evolution of the neutralizing antibody response to HIV type 1 infection
    2003 896 citations Douglas D. Richman, Susan J. Little et al. Proceedings of the National Academy of Sciences profile →
  10. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
    2012 878 citations Douglas D. Richman, Ronald J. Bosch et al. profile →
  11. Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
    2002 878 citations Susan J. Little, John W. Mellors et al. profile →
  12. Antiretroviral Therapy in Adults
    2000 874 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
  13. Antiretroviral Therapy for HIV Infection in 1998
    1998 837 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
  14. Antiretroviral Treatment of Adult HIV Infection
    2008 832 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
  15. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
    1997 782 citations Douglas D. Richman et al. Nature Medicine profile →
  16. Treatment for Adult HIV Infection
    2006 767 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
  17. HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
    2000 742 citations Celsa A. Spina, Douglas D. Richman et al. profile →
  18. The Challenge of Finding a Cure for HIV Infection
    2009 664 citations Douglas D. Richman et al. profile →
  19. Treatment for Adult HIV Infection
    2004 601 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
  20. Antiretroviral Treatment of Adult HIV Infection
    2010 595 citations Huldrych F. Günthard, Donna M. Jacobsen et al. profile →
  21. Antiretroviral Treatment for Adult HIV Infection in 2002
    2002 573 citations Donna M. Jacobsen, Douglas D. Richman et al. profile →
  22. Defective proviruses rapidly accumulate during acute HIV-1 infection
    2016 515 citations Katherine M. Bruner, Alexandra J. Murray et al. Nature Medicine profile →
  23. A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study
    1991 509 citations Albert W. Wu, Haya R. Rubin et al. Medical Care profile →
  24. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
    1994 487 citations Douglas D. Richman, Stephen A. Spector et al. Journal of Virology profile →
  25. Highly Precise Measurement of HIV DNA by Droplet Digital PCR
    2013 413 citations Matthew C. Strain, Steven M. Lada et al. profile →
  26. Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
    2013 385 citations Matthew C. Strain, Douglas D. Richman et al. profile →
  27. 2015 update of the drug resistance mutations in HIV-1
    2015 288 citations Vincent Cálvez, Victoria A. Johnson et al. PubMed profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Douglas D. Richman 39.2k 37.2k 13.0k 10.2k 7.1k 509 55.6k
David D. Ho 38.3k 1.0× 27.4k 0.7× 10.9k 0.8× 19.2k 1.9× 7.7k 1.1× 350 54.2k
Steven G. Deeks 27.4k 0.7× 22.4k 0.6× 10.0k 0.8× 12.6k 1.2× 5.6k 0.8× 567 45.1k
Anthony S. Fauci 32.9k 0.8× 25.0k 0.7× 20.3k 1.6× 34.9k 3.4× 11.1k 1.6× 796 95.6k
Robert F. Siliciano 26.2k 0.7× 17.2k 0.5× 5.6k 0.4× 11.6k 1.1× 5.6k 0.8× 308 31.5k
Bruce D. Walker 32.6k 0.8× 15.3k 0.4× 13.0k 1.0× 27.6k 2.7× 9.6k 1.4× 583 52.4k
Thomas C. Quinn 17.5k 0.4× 21.5k 0.6× 17.1k 1.3× 6.0k 0.6× 2.6k 0.4× 681 43.8k
George M. Shaw 25.1k 0.6× 14.2k 0.4× 7.7k 0.6× 11.9k 1.2× 5.4k 0.8× 236 32.1k
Richard A. Koup 22.9k 0.6× 13.9k 0.4× 9.4k 0.7× 24.4k 2.4× 6.4k 0.9× 309 42.6k
Daniel C. Douek 19.1k 0.5× 11.1k 0.3× 9.5k 0.7× 26.6k 2.6× 6.2k 0.9× 338 44.9k
Michael S. Saag 15.5k 0.4× 19.4k 0.5× 9.5k 0.7× 3.7k 0.4× 2.3k 0.3× 328 28.8k

Countries citing papers authored by Douglas D. Richman

Since Specialization
Citations

This map shows the geographic impact of Douglas D. Richman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas D. Richman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas D. Richman more than expected).

Fields of papers citing papers by Douglas D. Richman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas D. Richman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas D. Richman. The network helps show where Douglas D. Richman may publish in the future.

Co-authorship network of co-authors of Douglas D. Richman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas D. Richman. A scholar is included among the top collaborators of Douglas D. Richman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas D. Richman. Douglas D. Richman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wensing, Annemarie M. J., Charlotte Charpentier, Vincent Cálvez, et al.. (2025). Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance. Clinical Infectious Diseases. 81(4). e132–e136. 6 indexed citations
2.
Hermans, Lucas E., Sergio Carmona, Monique Nijhuis, et al.. (2020). Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study. PLoS Medicine. 17(2). e1003037–e1003037. 36 indexed citations
3.
Rosenbloom, Daniel I. S., Peter Bacchetti, Mars Stone, et al.. (2019). Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size. PLoS Computational Biology. 15(4). e1006849–e1006849. 17 indexed citations
4.
Hope, Thomas J., Douglas D. Richman, & Mario Stevenson. (2018). Encyclopedia of AIDS. 6 indexed citations
5.
Massanella, Marta, et al.. (2018). Improved assays to measure and characterize the inducible HIV reservoir. EBioMedicine. 36. 113–121. 38 indexed citations
6.
Lofano, Giuseppe, Matthew J. Gorman, Ashraf S. Yousif, et al.. (2018). Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement. Science Immunology. 3(26). 66 indexed citations
7.
Sadanand, Saheli, Jishnu Das, Amy W. Chung, et al.. (2017). Temporal variation in HIV-specific IgG subclass Abs during acute infection differentiates spontaneous controllers from chronic progressors. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations
8.
Bruner, Katherine M., Alexandra J. Murray, Ross A. Pollack, et al.. (2016). Defective proviruses rapidly accumulate during acute HIV-1 infection. Nature Medicine. 22(9). 1043–1049. 515 indexed citations breakdown →
9.
Gianella, Sara, Christy M. Anderson, Susanna R. Var, et al.. (2016). Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection. Journal of Virology. 90(8). 3944–3952. 55 indexed citations
10.
Wensing, Annemarie M. J., Vincent Cálvez, Huldrych F. Günthard, et al.. (2016). 2015 Update of the Drug Resistance Mutations in HIV-1.. PubMed. 23(4). 132–41. 56 indexed citations
11.
Wensing, Annemarie M. J., Vincent Cálvez, Huldrych F. Günthard, et al.. (2016). 2017 Update of the Drug Resistance Mutations in HIV-1.. PubMed. 24(4). 132–133. 149 indexed citations
12.
Torbett, Bruce E., David S. Goodsell, & Douglas D. Richman. (2015). The future of HIV-1 therapeutics : resistance is futile?. Springer eBooks. 2 indexed citations
13.
Agrawal, Arpita, et al.. (2012). Probing chelation motifs in HIV integrase inhibitors. Proceedings of the National Academy of Sciences. 109(7). 2251–2256. 40 indexed citations
14.
Binley, James Μ., Emma T. Crooks, Michael S. Seaman, et al.. (2008). Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C. Journal of Virology. 82(23). 11651–11668. 278 indexed citations
15.
Pillai, Satish K., Sergei L. Kosakovsky Pond, Yang Liu, et al.. (2006). Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain. 129(7). 1872–1883. 84 indexed citations
16.
Spina, Celsa A., Harry E. Prince, & Douglas D. Richman. (1997). Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro.. Journal of Clinical Investigation. 99(7). 1774–1785. 155 indexed citations
17.
Richman, Douglas D.. (1994). Resistance, Drug Failure, and Disease Progression. Aids Patient Care. 8(6). 317–321. 3 indexed citations
18.
Richman, Douglas D.. (1992). HIV Drug Resistance. AIDS Research and Human Retroviruses. 8(6). 1065–1071. 67 indexed citations
19.
Wu, Albert W., Haya R. Rubin, William C. Mathews, et al.. (1991). A Health Status Questionnaire Using 30 Items From The Medical Outcomes Study. Medical Care. 29(8). 786–798. 509 indexed citations breakdown →
20.
Reichman, Richard C., Gary J. Badger, Grégory Mertz, et al.. (1984). Treatment of Recurrent Genital Herpes Simplex Infections with Oral Acyclovir. A Controlled Trial. Obstetrical & Gynecological Survey. 39(9). 595–596. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David D. Ho Breakdown of academic impact, for papers by Steven G. Deeks Breakdown of academic impact, for papers by Anthony S. Fauci Breakdown of academic impact, for papers by Robert F. Siliciano Breakdown of academic impact, for papers by Bruce D. Walker Breakdown of academic impact, for papers by Thomas C. Quinn Breakdown of academic impact, for papers by George M. Shaw Breakdown of academic impact, for papers by Richard A. Koup Breakdown of academic impact, for papers by Daniel C. Douek Breakdown of academic impact, for papers by Michael S. Saag
Rankless by CCL
2026